Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis

Rheumatoid Arthritis

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort

Semin Arthritis Rheum

Llorca J, Ferraz-Amaro I, Castañeda S, Plaza Z, Sánchez-Alonso F, García-Gómez C, González-Juanatey C, González-Gay MÁ, CARMA Project Collaborative Group

doi: 10.1016/j.semarthrit.2025.152833

Rheumatoid Arthritis

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug

Arthritis Care Res (Hoboken)

Xie F, Beukelman T, McCormick NP, Curtis JR

doi: 10.1002/acr.80010

Rheumatoid Arthritis

Development and External Validation of a Genetic Risk Score for Pain in Rheumatoid Arthritis

Arthritis Care Res (Hoboken)

McMenamin KJ, Riley TR 4th, Wipfler K, Michaud K, Wheeler A, England BR, Sauer B, Wysham KD, Xiao R, March M, Cannon GW, Toikumo S, Kranzler HR, Kember RL, Mikuls TR, Baker JF

doi: 10.1002/acr.25588

Psoriatic Arthritis

Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44)

Ann Rheum Dis

Capelusnik D, Lopez-Medina C, van der Heijde D, Aletaha D, Smolen J, Molto A, Ramiro S

doi: 10.1016/j.ard.2025.08.027

Psoriatic Arthritis

Disease activity and hyperuricemia predict the development of cardiovascular events in patients with Psoriatic Arthritis: results of the 10-year prospective evaluation in the CARMA cohort

Semin Arthritis Rheum

Llorca J, Ferraz-Amaro I, Moreno-Martínez MJ, Plaza Z, Sánchez-Alonso F, Moreno-Ramos MJ, García-Gómez C, Castañeda S, González-Juanatey C, González-Gay MÁ, CARMA Project Collaborative Group

doi: 10.1016/j.semarthrit.2026.152923

Rheumatoid Arthritis

Towards the development of a definition of independence for individuals diagnosed with rheumatoid arthritis in remission: an 'OMERACT remission in rheumatoid arthritis patient perspective' special interest group report

Semin Arthritis Rheum

Gazel U, Barnes E, Jones B, Terrett A, Voshaar M, Hoogland W, March L, Beaton D, Khoo T, Chin A, Shea B, Tugwell P, Proudman S, Flurey CA

doi: 10.1016/j.semarthrit.2026.152948

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Rheumatoid Arthritis

Objectively measured sleep disorders in rheumatoid arthritis and their association with disease activity

Arthritis Care Res (Hoboken)

Katz P, Patterson SL, Nakamura MC, Prather AA, Park J, Stone KL

doi: 10.1002/acr.25685

Rheumatoid Arthritis

Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis

Ann Rheum Dis

He Y, Sareila O, Johansson L, Agelii ML, Cheng L, Lundquist A, Lönnblom E, Gröndal G, Gudbjornsson B, Hørslev-Petersen K, Lampa J, Lend K, Hetland ML, Nordström D, Nurmohamed M, Rudin A, Uhlig T, Østergaard M, Gjertsson I, Rantapää-Dahlqvist S, Holmdahl R

doi: 10.1016/j.ard.2025.04.013

Related content

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug

Development and External Validation of a Genetic Risk Score for Pain in Rheumatoid Arthritis

Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44)

Disease activity and hyperuricemia predict the development of cardiovascular events in patients with Psoriatic Arthritis: results of the 10-year prospective evaluation in the CARMA cohort

Towards the development of a definition of independence for individuals diagnosed with rheumatoid arthritis in remission: an 'OMERACT remission in rheumatoid arthritis patient perspective' special interest group report

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Objectively measured sleep disorders in rheumatoid arthritis and their association with disease activity

Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis